These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2413325)

  • 21. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
    Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
    Matsuda LA; Schmidt CJ; Hanson GR; Gibb JW
    Neuropharmacology; 1986 Mar; 25(3):249-55. PubMed ID: 2871513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
    Heikkila RE
    Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD; Ramirez VD
    Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
    Russ H; Mihatsch W; Gerlach M; Riederer P; Przuntek H
    Neurosci Lett; 1991 Feb; 123(1):115-8. PubMed ID: 1712088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism?
    Collins MA; Neafsey EJ
    Neurosci Lett; 1985 Apr; 55(2):179-84. PubMed ID: 2582318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.
    Chiueh CC; Markey SP; Burns RS; Johannessen JN; Pert A; Kopin IJ
    Eur J Pharmacol; 1984 Apr; 100(2):189-94. PubMed ID: 6203759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine.
    Mihatsch W; Russ H; Przuntek H
    J Neural Transm; 1988; 71(3):177-88. PubMed ID: 3128644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig.
    Perry TL; Yong VW; Ito M; Jones K; Wall RA; Foulks JG; Wright JM; Kish SJ
    Life Sci; 1985 Apr; 36(13):1233-8. PubMed ID: 2858797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Di Paolo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():27-38. PubMed ID: 25046277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.
    Guttman M; Fibiger HC; Jakubovic A; Calne DB
    J Neurochem; 1990 Apr; 54(4):1329-34. PubMed ID: 1690267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
    Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of amine substituted analogues of MPTP as unique tools for the study of MPTP toxicity and Parkinson's disease.
    Johannessen JN; Savitt JM; Markey CJ; Bacon JP; Weisz A; Hanselman DS; Markey SP
    Life Sci; 1987 Feb; 40(8):697-704. PubMed ID: 2433563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis.
    Skirboll S; Wang J; Mefford I; Hsiao J; Bankiewicz KS
    Exp Neurol; 1990 Nov; 110(2):187-93. PubMed ID: 1699780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP.
    Enz A; Hefti F; Frick W
    Eur J Pharmacol; 1984 May; 101(1-2):37-44. PubMed ID: 6086364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
    Miyake H; Chiueh CC
    Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.